Receptor Agonist
PT-141
$79.00
Form Vial
Selected: Vial · 10mg — $79.00
PT-141 is bremelanotide, a synthetic cyclic melanocortin receptor agonist derived from melanotan-related peptide research, with laboratory applications centered on melanocortin receptor signaling, central nervous system pathways, and receptor pharmacology.
Documentation pending
Research highlights
- Bremelanotide, a synthetic cyclic melanocortin receptor agonist derived from melanotan-related peptide research
- Research interest: melanocortin receptor signaling, central nervous system pathways, and receptor pharmacology
- This places it within receptor-pharmacology research, where binding, downstream signaling, and pathway selectivity are central experimental questions
- Product identity and experimental context matter, and results from preclinical or in-vitro work should not be treated as established clinical outcomes
Shipping calculated at checkout.
Questions before ordering? Contact support
- Product documentation
- Secure checkout
- Shipping communication
- Customer support
For laboratory research use only. Not for human or veterinary use.
- Product name
- PT-141
- Form
- Vial
- Specification
- 10mg
- Category
- Receptor Agonist
- Research classification
- Research use only
Related
More in Receptor Agonist
